University of Groningen / Rijksuniversiteit Groningen
University / College
Location:
Groningen,
Netherlands (NL)
ISNI: 0000000404071981
ROR: https://ror.org/012p63287
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer (2017)
Koch M, De Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams ALL, Kranendonk MEG, et al.
Journal article
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) (2017)
Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, et al.
Journal article, Review article
Using patient self-reports to study heterogeneity of treatment effects in major depressive disorder (2017)
Kessler RC, Van Loo HM, Wardenaar KJ, Bossarte RM, Brenner LA, Ebert D, De Jonge P, et al.
Journal article
Study of the LOFAR radio self-trigger and single-station acquisition mode (2017)
Bonardi A, Buitink S, Corstanje A, Falcke H, Hare BM, Hörandel JR, Mitra P, et al.
Conference contribution
Expansion of the LOFAR radboud air shower array (2017)
Mulrey K, Bonardi A, Buitink S, Corstanje A, Falcke H, Hare BM, Hörandel JR, et al.
Conference contribution
Overview and status of the lunar detection of cosmic particles with LOFAR (2017)
Winchen T, Bonardi A, Buitink S, Corstanje A, Falcke H, Hare BM, Hörandel JR, et al.
Conference contribution
The effect of the atmospheric refractive index on the radio signal of extensive air showers using Global Data Assimilation System (GDAS) (2017)
Corstanje A, Mitra P, Bonardi A, Buitink S, Falcke H, Hare BM, Hörandel JR, et al.
Conference contribution
Characterisation of the radio frequency spectrum emitted by high energy air showers with LOFAR (2017)
Rossetto L, Bonardi A, Buitink S, Corstanje A, Falcke H, Hare BM, Hörandel JR, et al.
Conference contribution
HIGH-ENERGY COSMIC RAYS: GALACTIC OR EXTRAGALACTIC? (2017)
Hörandel JR, Achterberg A, Buitink S, Corstanje A, Falcke H, Nelles A, Rachen JP, et al.
Conference contribution
Fluorescently labeled bevacizumab in human breast cancer: Defining the classification threshold (2017)
Koch M, De Jong JS, Glatz J, Symvoulidis P, Lamberts LE, Adams ALL, Kranendonk MEG, et al.
Conference contribution